NFB is the most important transcription factor activating the expression of numerous pro-inflammatory cytokine genes such as interleukin-1 (IL-1), IL-6, and tumor necrosis factor-alpha (TNF) each of which have been shown to be involved in promoting IR
You should contact your GP or specialist promptly if you experience any of the following whilst using HGH or any investigational compound: Unexplained changes in blood glucose levels , including symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination, fatigue) Persistent nausea, vomiting, or abdominal pain , which may indicate gastrointestinal complications Swelling of the hands, feet, or face , which could suggest fluid retention Severe or persistent headache , or any change in vision, which may rarely indicate raised intracranial pressure Injection site reactions , including redness, swelling, or signs of infection Call 999 or attend your nearest A&E immediately if you experience chest pain, severe shortness of breath, palpitations, or any symptoms that could suggest a stroke or severe allergic reaction
Several drugs are currently in advanced clinical trials: Phase III Clinical Trials: IBI362 (Innovent/Eli Lilly), CagriSema (Novo Nordisk), Retatrutide (Eli Lilly), and Survodutide (Boehringer Ingelheim)
4I), suggesting that it inhibits its stability
Combined with TSH, free T4, and free T3 labs, it guides personalized dosing
